Pfizer's mRNA flu shot outperforms standard flu vaccine in late-stage trial

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Moderna takes $1.5 billion loan, expects 10% revenue growth next year

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue ...
Fierce Biotech

Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Notable healthcare headlines for the week: Pfizer, Novo Nordisk, Moderna in focus

Get the latest stock market update and key takeaways in healthcare, including Pfizer, Amgen, Novo Nordisk results, and obesity drug bidding wars.
WSB Radio

COVID-19 vaccines may help some cancer patients fight tumors

WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin ...

Moderna to Invest $140 Million in Expanding U.S. Manufacturing

Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...
Newser on MSN

Pfizer's New Flu Shot Could Be a 'Game Changer'

A new mRNA-based flu vaccine from Pfizer has shown greater effectiveness than the standard flu shot in a large Phase 3 trial, according to results published in the New England Journal of Medicine. The ...

Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval ...